On March 7, 2018 Novavax, Inc. (Nasdaq:NVAX) reported it will provide a corporate update and report its fourth quarter and full year 2017 financial and operating results following the close of U.S. financial markets on Wednesday, March 14, 2018 (Press release, Novavax, MAR 7, 2018, http://ir.novavax.com/news-releases/news-release-details/novavax-host-conference-call-and-webcast-provide-corporate [SID1234524619]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference call and webcast details are as follows:

Date: March 14, 2018

Time: 5:00 p.m. U.S. Eastern Time (ET)

Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)

Passcode: 6472939

Webcast: www.novavax.com, "Investors"/ "Events"

Conference call and webcast replay:

Dates: Starting at 8:00 p.m. ET, March 14, 2018 until

9:00 p.m. ET March 21, 2018

Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)

Passcode: 6472939

Webcast: www.novavax.com, "Investors"/ "Events", until June 14